Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Anti-inflammatory medications are a cornerstone of treatment for mixed connective tissue disease (MCTD) but your diet also is important. Eating foods that suppress inflammation may help prevent ...

Patients with connective tissue diseases who experienced ... (1.8%), primary Sjögren syndrome (1.1%), and mixed connective tissue disease (MCTD; 0.04%). Patients with MCTDs were excluded from ...

Mixed connective tissue disease (MCTD) is a complex overlap disease with features of different autoimmune connective tissue diseases (CTDs) namely systemic sclerosis, poly/dermatomyositis and systemic ...

Rare and complex connective tissue diseases comprise a large number of diseases and syndromes including hereditary (Ehlers-Danlos syndromes and related disorders), rare systemic immune-mediated ...

Psoriatic Arthritis vs. Mixed Connective Tissue Disease: What Are the Differences? Psoriatic Arthritis vs. Multiple Sclerosis: What Are the Differences? Psoriatic Arthritis vs. Lupus: What Are the ...